Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
BigBear.ai Holdings
BBAI
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
BIOA BioAge Labs
- 4.630
- +0.260+5.95%
Close Feb 28 16:00 ET
- 4.640
- +0.010+0.21%
Post 20:01 ET
165.98MMarket Cap-2.23P/E (TTM)
4.660High4.360Low309.08KVolume4.500Open4.370Pre Close1.41MTurnover2.94%Turnover RatioLossP/E (Static)35.85MShares26.62052wk High0.53P/B48.62MFloat Cap3.85052wk Low--Dividend TTM10.50MShs Float26.620Historical High--Div YieldTTM6.86%Amplitude3.850Historical Low4.576Avg Price1Lot Size
BioAge Labs Stock Forum
Sign in to post a comment
$BioAge Labs (BIOA.US)$ $
BioArctic's Alzheimer's Drug Clears Critical EU Regulatory Hurdle After Safety Evaluation
BioArctic's Alzheimer's Drug Clears Critical EU Regulatory Hurdle After Safety Evaluation
1
$BioAge Labs (BIOA.US)$
Alzheimer's Drug Deal: How BioArctic's $1.3B Bristol Myers Agreement Could Transform Treatment
Alzheimer's Drug Deal: How BioArctic's $1.3B Bristol Myers Agreement Could Transform Treatment
$BioAge Labs (BIOA.US)$
BioArctic AB announced the completion of its global license agreement with Bristol Myers Squibb after receiving U.S. Federal Trade Commission clearance. The agreement, initially announced on December 19, 2024, grants Bristol Myers Squibb worldwide development and commercialization rights for BAN1503 and BAN2803, part ...
BioArctic AB announced the completion of its global license agreement with Bristol Myers Squibb after receiving U.S. Federal Trade Commission clearance. The agreement, initially announced on December 19, 2024, grants Bristol Myers Squibb worldwide development and commercialization rights for BAN1503 and BAN2803, part ...
4
$BioAge Labs (BIOA.US)$
Milestone Achievement: Alzheimer's Breakthrough Leqembi Reaches €200M Sales, Triggering Major Payout
Milestone Achievement: Alzheimer's Breakthrough Leqembi Reaches €200M Sales, Triggering Major Payout
1
The attention of AI Medteck stocks are rapidly increasing.
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...
113
13
279
$BioAge Labs (BIOA.US)$ no volume
$BioAge Labs (BIOA.US)$ this one dead
$BioAge Labs (BIOA.US)$ Dead. No more hope
$BioAge Labs (BIOA.US)$
BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs
Tuesday, 28th January at 9:00 am
Advancement of next-generation APJ agonists with discontinuation of azelaprag
Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial Ph1 clinical data anticipated by end of 2025
Expansion of discovery efforts based on insights from BioAge's platform, including a target identification collaboration with Novartis and a newly announced antibo...
BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs
Tuesday, 28th January at 9:00 am
Advancement of next-generation APJ agonists with discontinuation of azelaprag
Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial Ph1 clinical data anticipated by end of 2025
Expansion of discovery efforts based on insights from BioAge's platform, including a target identification collaboration with Novartis and a newly announced antibo...
2
1
$BioAge Labs (BIOA.US)$ this stock is dead
No comment yet
103459086 : Please refrain from posting unrelated companies. this has nothing to do with BioAge Labs! Pls read the materials first before posting and tagging!